Hydroxyurea Suppliers & Bulk Manufacturers

Available Forms: Capsules and Tablets

Available Strengths: Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg

Reference Brands: Hydrea, Droxia , Siklos

Category: Anemia

Hydroxyurea is an oral cytoreductive drug used for sickle cell disease, CML, and polycythemia vera. Available in 100–500 mg strengths under brands like Hydrea, Droxia, and Siklos. Ideal for pharma B2B sourcing and global bulk supply. Hydroxyurea is available in Capsules and Tablets and strengths such as Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Hydroxyurea is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Hydroxyurea can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Hydroxyurea is a widely used oral chemotherapeutic and hematologic drug indicated for sickle cell disease, chronic myeloid leukemia (CML), polycythemia vera, and essential thrombocythemia. It works by inhibiting DNA synthesis and increasing fetal hemoglobin (HbF) in sickle cell patients. Marketed under brands like Hydrea, Droxia, and Siklos, it is available in 100 mg to 500 mg capsules and tablets. Manufactured under GMP standards, Hydroxyurea is ideal for pharmaceutical distributors, hospitals, and global B2B buyers. We offer competitive pricing, regulatory documentation, and reliable bulk supply. Contact us today for high-quality Hydroxyurea sourcing and international export support.